CureVac N.V. Announces Annual Shareholder Meeting Date
| Field | Detail |
|---|---|
| Company | Curevac N.V. |
| Form Type | 6-K |
| Filed Date | May 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
CureVac's AGM is June 24, 2025. Materials are out.
AI Summary
On May 23, 2025, CureVac N.V. announced that its annual general meeting of shareholders will be held on June 24, 2025. The company also made certain materials available to shareholders in connection with this meeting. This filing is a report of a foreign private issuer.
Why It Matters
This filing informs shareholders about the upcoming annual meeting and related materials, which is a standard corporate governance event.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a shareholder meeting and does not contain new financial or operational information.
Key Players & Entities
- CureVac N.V. (company) — Registrant
- May 23, 2025 (date) — Announcement Date
- June 24, 2025 (date) — Annual General Meeting Date
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report that CureVac N.V. convened its annual general meeting of shareholders on May 23, 2025, and made certain materials available to shareholders in connection with the meeting scheduled for June 24, 2025.
When is CureVac N.V.'s annual general meeting of shareholders scheduled to take place?
The annual general meeting of shareholders is scheduled to be held on June 24, 2025.
What action did CureVac N.V. take on May 23, 2025, regarding the shareholder meeting?
On May 23, 2025, CureVac N.V. convened the annual general meeting of shareholders and made available to its shareholders certain other materials in connection with such meeting.
Is the information in this Form 6-K considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934?
No, the information in this Form 6-K (including Exhibit 99.1) shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
What is the principal executive office address for CureVac N.V.?
The principal executive office address for CureVac N.V. is Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 23, 2025 regarding CureVac N.V..